NCT02871908View on ClinicalTrials.gov

Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
DiarrheaAntibiotic Associated Diarrhea
Interventions
DRUG

Lactobacillus reuteri DSM 17938

Lactobacillus reuteri DSM 17938 twice daily 2 x 10\^8

DRUG

Placebo

Placebo

Trial Locations (1)

02-091

Department of Paediatrics, The Medical University of Warsaw, Poland, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT02871908 - Lactobacillus Reuteri DSM 17938 in the Prevention of Antibiotic-associated Diarrhea in Children: Protocol of a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter